ILDSTAD SUZANNE (Chief Scientific Officer) reported 2 transactions at TOURMALINE BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/2/2022ACC: 0000899243-22-004205
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.35M acquired · 1.20M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.20M
Price / share
—
Trade value
—
% of position
25.0%
11/17/2021
4.81M→3.61M
Common Stock
Indirect
Shares
+1.20M
Price / share
—
Trade value
—
% of position
New position
11/17/2021
0.00→1.20M
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2021 | G · Gift | −1.20M | — | — | 25.0% | 4.81M | 3.61M |
| Common Stock Indirect | 11/17/2021 | G · Gift | +1.20M | — | — | New position | 0.00 | 1.20M |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
150K shares
Shares
+150K
Strike price
9.10
Held after
150K
Exercisable
—
2/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock150K shares | 2/1/2022 | A · Award | +150K | 9.10 | — | 150K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned654.21K
Total
1.31M indirect1.31M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 654.21K | Indirect |
| Total | 1.31M | 1.31M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported